Gut microbiota-derived indole-3-propionic acid alleviates endoplasmic reticulum stress by regulating FMO2 in MASLD

Yue Luo1, Yuefeng Zhang1, Qian Zhang1

  • 1School of Pharmaceutical Sciences (Shenzhen), Sun Yat-sen University, Shenzhen, China.

Abstract

Insights

Indole-3-propionic acid (IPA) supplementation improves metabolic dysfunction-associated steatotic liver disease (MASLD) by restoring gut microbiota and reducing liver fat. IPA targets the FMO2/PERK pathway to alleviate endoplasmic reticulum stress.

Area of Science:

  • Hepatology
  • Microbiome Research
  • Metabolic Diseases

Background:

  • Metabolic dysfunction-associated steatotic liver disease (MASLD) is a growing global health concern with no approved treatments.
  • The role of gut microbiota metabolites, like Indole-3-propionic acid (IPA), in MASLD pathogenesis is not fully understood.
  • Investigating IPA's molecular mechanisms is crucial for developing novel therapeutic strategies.

Purpose of the Study:

  • To elucidate the molecular mechanisms underlying the effects of Indole-3-propionic acid (IPA) in the development of metabolic dysfunction-associated steatotic liver disease (MASLD).
  • To evaluate the therapeutic potential of IPA in a mouse model of MASLD.

Main Methods:

  • Comparative metabolomic analysis of serum and fecal samples from MASLD and normal mice.
  • In vivo studies using a MASLD mouse model and in vitro studies using cell models to assess IPA's effects.
  • Transcriptome analysis, flow cytometry, western blotting, RNA interference, and immunoprecipitation for mechanistic validation.

Main Results:

  • Serum and fecal IPA levels were significantly reduced in MASLD mice.
  • IPA supplementation ameliorated hepatic lipid accumulation, insulin resistance, liver damage, and steatosis, while restoring gut microbiota balance.
  • Mechanistically, IPA promotes FMO2 expression, which inhibits the PERK/eIF2α/ATF4/CHOP pathway, reducing endoplasmic reticulum stress, hepatocyte apoptosis, and reactive oxygen species.

Conclusions:

  • IPA enhances FMO2 expression, leading to FMO2-PERK binding in hepatocytes, inhibiting PERK phosphorylation and subsequent ER stress.
  • This mechanism reduces hepatocyte apoptosis and oxidative stress, offering a novel therapeutic approach for MASLD.
  • The IPA/FMO2/PERK axis represents a potential therapeutic target for managing ER stress in MASLD.

Related Concept Videos

Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Stringent Response in E. coli01:23

Stringent Response in E. coli

Bacterial growth is closely tied to nutrient availability, with cells proliferating exponentially under favorable conditions and entering a stationary phase when resources become scarce. This transition is mediated by a regulatory mechanism known as the stringent response, which allows bacteria to adapt to nutrient deprivation by modulating gene expression and metabolic activity.During nutrient scarcity, intracellular amino acid levels decline. It results in the accumulation of uncharged tRNAs...
Microbiota of the Large Intestine01:27

Microbiota of the Large Intestine

The large intestine hosts the most densely populated microbial ecosystem in the human body. This complex community primarily consists of anaerobic bacteria, with Bacillota (formerly Firmicutes) and Bacteroidota (formerly Bacteroidetes) as the predominant groups. The distribution of these microbes varies along different sections of the large intestine, influenced by local environmental factors such as oxygen availability and nutrient composition.The cecum, located at the beginning of the large...
Functions of the Gut Microbiota01:18

Functions of the Gut Microbiota

The gut microbiota includes trillions of microorganisms that colonize the human gastrointestinal tract, including bacteria, archaea, viruses, and fungi. This complex ecosystem plays a critical role in maintaining intestinal and systemic health. Most of these microbes inhabit the large intestine, establishing a relatively stable and diverse community that contributes to gut homeostasis through various metabolic, immunological, and protective mechanisms.Dominant bacterial phyla, such as...
Dysbiosis of the Gut Microbiota01:18

Dysbiosis of the Gut Microbiota

The human gut microbiome includes a diverse array of microbial species, including beneficial commensals and opportunistic pathogens, which interact to support host health. These microbes contribute to essential functions such as nutrient metabolism, immune system modulation, and maintenance of intestinal barrier integrity. However, disruptions to this equilibrium—referred to as dysbiosis—can have widespread physiological consequences.Dysbiosis is often characterized by reduced microbial...
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...